- Our Doctors
- A/Prof. Tim Wang
![Dr Tim Wang](/content/dam/genesiscare/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_ProfTim%20Wang.jpg)
/content/dam/genesiscare/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_ProfTim Wang.jpg
A/Prof Tim Wang
A/Prof Tim Wang
Tim
Wang
MBBS, MPH, FRANZCR, Radiation Oncologist
Languages spoken
English, Mandarin
Overview
Centres
Macquarie University Hospital (Oncology)
Hospital Building, Suite 1, Level B2, 3 Technology Place, Macquarie University, NSW, 2109, Australia
Macquarie University Hospital (Oncology)
Hospital Building, Suite 1, Level B2, 3 Technology Place, Macquarie University, NSW, 2109, Australia
-33.77308982351843, 151.11793004035897
/au/our-centres/macquarie-university-hospital
NSW
Clinical interests
Clinical interests in breast cancer, melanoma, liver malignancies, and upper gastrointestinal (GI) malignancies.
Dr Tim (Wei) Wang is a senior radiation oncologist with subspecialty interest including the management of breast cancer, melanoma, liver tumours and upper GI cancer. He has a clinical interest in radiation treatment techniques, and the interaction of radiation therapy with modern systemic therapies. He is the trial chairperson of several ongoing collaborative group clinical trials. Dr Wang is a Clinical Senior Lecturer for the University of Sydney since 2011.
Professional memberships
- RANZCR
- TROG
- AGITG
- MSCT
- ANZBCTG
![](/content/dam/genesiscare/icons,-logos/icons/publication_icon.jpg)
Publications
- R. Mercieca-Bebber, E. H. Barnes, K. Wilson, Z. Samoon, E. Walpole, T. Mai, S. Ackland, M. Burge, G. Dickie, D. Watson, J. Leung, T. Wang, R. Bohmer, D. Cameron, J. Simes, V. Gebski, M. Smithers, J. Thomas, J. Zalcberg & A. P. Barbour. Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma. BMC Cancer (2022) DOI:10.1186/s12885-022-09270-4
- Siujoon Choi, Angela Hong, Tim Wang, Seringe Lo, Bi Chen, Ines Silva, Rony Kapoor, Edward Hsiao, Gerald B Fogarty, Matteo S Carlino, Alexander M Menzies, Georgina V Long, Brindha S Shivalingam. Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location. Strahlenther Onkol (2021)
- Phuong Dinh, J. Dinny Graham, Elisabeth N. Elder, Masrura Kabir, Tram B. Doan, James French, Farid Meybodi, Rina Hui, Nicholas R. Wilcken, Paul R. Harnett, Jeremy Hsu, Kirsty E. Stuart, Tim Wang, Verity Ahern, Meagan Brennan, Stephen B. Fox, Rachel F. Dear, Elgene Lim, Michelle White, G. Bruce Mann, Nirmala Pathmanathan. Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor positive early breast cancer patients: benefits of physician selective testing. Breast Cancer Research and Treatment (2021)
- Elissa J Zhang, Kirsty Stuart, Rina Hui, Wei Wang, Verity Ahern, Farid Meybodi, James French, Elisabeth Elder, ME Brennan. Management of early breast cancer at an Australian NSW cancer centre during the early phase of COVID-19 pandemic. Archives of Breast Cancer (2021)
- Cora Waldstein, Trevor Moodie, Simon Ashworth, Verity Ahern, Kirsty Stuart, Wei Wang. Feasibility of arm-draining lymph node-sparing radiotherapy of breast cancer: A pilot planning study. Journal of medical imaging and radiation oncology (2021)
- Wei Wang, Jessica Louise Smith, Matteo Salvatore Carlino, Bryan Burmeister, Mark Blayne Pinkham, Gerald Blaise Fogarty, David Robert Harry Christie, Vanessa Estall, Mark Shackleton, Arthur Clements, Rory Wolfe, Le Thi Phuong Thao, Elizabeth Jane Paton, Victoria Steel, Narelle Catherine Williams. Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma. Clinical and translational radiation oncology (2021)